Literature DB >> 22592896

Persistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosis.

Mauro Maioli1, Anna Toso, Mario Leoncini, Michela Gallopin, Nicola Musilli, Francesco Bellandi.   

Abstract

BACKGROUND: The temporal evolution of renal function in patients with acute kidney injury after contrast medium (CI-AKI) is not well known. The aim of this observational study was to evaluate the incidence, risk factors, and prognostic implications of persistent renal damage (RD) in patients with preexistent moderate-to-severe renal dysfunction. METHODS AND
RESULTS: From June 2003 to March 2008, 3986 patients underwent coronary angiography at our institution; 1490 of 3986 had an estimated creatinine clearance of <60 mL/min and were enrolled. CI-AKI was defined as an absolute increase ≥ 0.5 mg/dL over baseline serum creatinine within 3 days after the administration of contrast medium (iodixanol). In patients who developed CI-AKI, persistent RD was defined as a relative decrease of creatinine clearance ≥ 25% over baseline at 3 months. Patients whose creatinine clearance returned to baseline (or nearly) were classified as transient RD. The overall incidence of CI-AKI was 12.1%, and persistent RD occurred in 18.6% of CI-AKI patients. At Cox regression analysis, nephropathy risk score ≥ 17, left ventricular ejection fraction ≤ 30%, and increased value of serum creatinine ≥ 1.5-fold from baseline within 5 days were found to be significant risk factors for persistent RD. At 5 years, the incidence of death was significantly higher in patients with persistent RD than in both patients with transient RD (P=0.015) and those without CI-AKI (P=0.0001). A similar trend was observed for the combined end point of death, dialysis and cardiovascular events.
CONCLUSIONS: These results suggest that CI-AKI is not always a transient, benign creatininopathy, but rather a direct cause of worsening renal function. The occurrence of CI-AKI can identify patients at increased risk of cardiovascular events.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22592896     DOI: 10.1161/CIRCULATIONAHA.111.085290

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  68 in total

1.  Efficacy of short-term cordyceps sinensis for prevention of contrast-induced nephropathy in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention.

Authors:  Kai Zhao; Yu Lin; Yong-Jian Li; Sheng Gao
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Reducing Acute Kidney Injury Due to Contrast Material: How Nurses Can Improve Patient Safety.

Authors:  Peggy Lambert; Kristine Chaisson; Susan Horton; Carmen Petrin; Emily Marshall; Sue Bowden; Lynn Scott; Sheila Conley; Janette Stender; Gertrude Kent; Ellen Hopkins; Brian Smith; Anita Nicholson; Nancy Roy; Brenda Homsted; Cindy Downs; Cathy S Ross; Jeremiah Brown
Journal:  Crit Care Nurse       Date:  2017-02       Impact factor: 1.708

Review 3.  How to balance risks and benefits in the management of CKD patients with coronary artery disease.

Authors:  Giancarlo Marenzi; Nicola Cosentino; Carlo Guastoni
Journal:  J Nephrol       Date:  2015-02-25       Impact factor: 3.902

Review 4.  Contrast medium induced acute kidney injury: a narrative review.

Authors:  Valentina Pistolesi; Giuseppe Regolisti; Santo Morabito; Ilaria Gandolfini; Silvia Corrado; Giovanni Piotti; Enrico Fiaccadori
Journal:  J Nephrol       Date:  2018-05-25       Impact factor: 3.902

5.  Guideline on the use of iodinated contrast media in patients with kidney disease 2018.

Authors:  Yoshitaka Isaka; Hiromitsu Hayashi; Kazutaka Aonuma; Masaru Horio; Yoshio Terada; Kent Doi; Yoshihide Fujigaki; Hideo Yasuda; Taichi Sato; Tomoyuki Fujikura; Ryohei Kuwatsuru; Hiroshi Toei; Ryusuke Murakami; Yoshihiko Saito; Atsushi Hirayama; Toyoaki Murohara; Akira Sato; Hideki Ishii; Tadateru Takayama; Makoto Watanabe; Kazuo Awai; Seitaro Oda; Takamichi Murakami; Yukinobu Yagyu; Nobuhiko Joki; Yasuhiro Komatsu; Takamasa Miyauchi; Yugo Ito; Ryo Miyazawa; Yoshihiko Kanno; Tomonari Ogawa; Hiroki Hayashi; Eri Koshi; Tomoki Kosugi; Yoshinari Yasuda
Journal:  Clin Exp Nephrol       Date:  2020-01       Impact factor: 2.801

6.  Effect of Contrast-Induced Nephropathy on the Long-Term Outcome of Patients with Non-ST Segment Elevation Myocardial Infarction.

Authors:  Burak Turan; Ayhan Erkol; Mehmet Gül; Uğur Fındıkçıoğlu; İsmail Erden
Journal:  Cardiorenal Med       Date:  2015-02-28       Impact factor: 2.041

7.  Limb ischemia protects against contrast-induced nephropathy.

Authors:  Joseph V Bonventre
Journal:  Circulation       Date:  2012-06-26       Impact factor: 29.690

8.  Arterial spin labelling MRI to measure renal perfusion: a systematic review and statement paper.

Authors:  Aghogho Odudu; Fabio Nery; Anita A Harteveld; Roger G Evans; Douglas Pendse; Charlotte E Buchanan; Susan T Francis; María A Fernández-Seara
Journal:  Nephrol Dial Transplant       Date:  2018-09-01       Impact factor: 5.992

9.  Preventing contrast-induced acute kidney injury in the emergency room.

Authors:  Koichiro Homma; Tadashi Yoshida; Joe Yoshizawa; Masaru Suzuki; Junichi Sasaki; Jun Namiki; Matsuhiko Hayashi; Shingo Hori
Journal:  Acute Med Surg       Date:  2015-05-28

10.  Successful carbon dioxide angiography guided endovascular thrombectomy of the superficial femoral artery in a young patient with critical limb ischemia.

Authors:  Sorin Giusca; Tom Eisele; Dorothea Raupp; Christoph Eisenbach; Grigorios Korosoglou
Journal:  Heart Vessels       Date:  2016-09-23       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.